These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8808807)

  • 21. [Indication and results of surgical treatment of intermittent claudication].
    Ishimaru S; Shimizu T; Yamazaki T; Furukawa K
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1046-8. PubMed ID: 1470114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease.
    Kawano T; Saito T; Yasu T; Saito T; Nakamura T; Namai K; Tamemoto H; Kawakami M; Saito M; Ishikawa SE
    Metabolism; 2005 May; 54(5):653-6. PubMed ID: 15877296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebrovascular diseases in patients with arteriosclerotic aortic aneurysm and arteriosclerosis obliterans studied by carotid ultrasonography and by computed tomography of the brain].
    Iwamoto T; Sugiyama T; Oyama T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 1998 Sep; 35(9):673-9. PubMed ID: 9865061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic evaluation of patients with arteriosclerosis obliterans].
    Landi A; Osgyán T; Gálos G; Keller L
    Orv Hetil; 1994 Oct; 135(41):2253-7. PubMed ID: 7970639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease.
    Zak I; Sarecka-Hujar B; Krauze J
    Kardiol Pol; 2008 Apr; 66(4):380-6; discussion 387. PubMed ID: 18473266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke prevention: management of modifiable vascular risk factors.
    Leys D; Deplanque D; Mounier-Vehier C; Mackowiak-Cordoliani MA; Lucas C; Bordet R
    J Neurol; 2002 May; 249(5):507-17. PubMed ID: 12021938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors in stable coronary disease. Relationship with ischemic threshold and prognostic implications].
    Salcedo A; Echevarría P; Molinero E; Sagastagoitia D; Aguirre JM; Iriarte MM; Laka Mugarza JP
    Med Clin (Barc); 1996 Mar; 106(10):372-7. PubMed ID: 8637276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men.
    Paffenbarger RS; Hyde RT; Wing AL; Lee IM; Jung DL; Kampert JB
    N Engl J Med; 1993 Feb; 328(8):538-45. PubMed ID: 8426621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between white blood cell count and several risk factors for coronary heart disease in patients with systemic hypertension.
    Capuano V; Lamaida N; Mazzotta G; Scotto di Quacquaro G
    G Ital Cardiol; 1998 May; 28(5):530-5. PubMed ID: 9646068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Principle of treatment of intermittent claudication due to arteriosclerosis obliterans--reconstruction or conservative treatment].
    Hachiya T; Kaneko H; Shiraishi A; Unno N; Baba S; Sakaguchi S; Koyano K
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1040-2. PubMed ID: 1470112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of coronary risk factors and coronary arteriosclerosis for coronary vasospasm].
    Kido S; Ishii Y; Hasebe N; Ido A; Kawashima E; Ogawa Y; Yamashita H; Kikuchi K; Onodera S
    J Cardiol; 1998 Mar; 31(3):135-43. PubMed ID: 9557276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial epidemiological surveys in an urban Indian population demonstrate increasing coronary risk factors among the lower socioeconomic strata.
    Gupta R; Gupta VP; Sarna M; Prakash H; Rastogi S; Gupta KD
    J Assoc Physicians India; 2003 May; 51():470-7. PubMed ID: 12974428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arteriosclerosis, risk factors and the hemostasis system].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(1):113-7. PubMed ID: 3363496
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum lipids and lipoproteins in peripheral vascular disease].
    Umemoto T
    Nihon Geka Gakkai Zasshi; 1985 Jan; 86(1):84-97. PubMed ID: 3974570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
    Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
    Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans.
    Liu Y; Cui Y; Zhou Z; Liu B; Liu Z; Li G
    Dis Markers; 2023; 2023():1316821. PubMed ID: 36865500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.